← Back to Search

MDC Mobile App for Diabetes

N/A
Waitlist Available
Led By William Martinez, MD, MS
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month follow-up (t1)
Awards & highlights

Study Summary

This trial will study a new diabetes care mobile intervention to see how well it works and how users interact with it.

Who is the study for?
This trial is for adults aged 18-75 with Type 2 Diabetes who are on medication and attend Vanderbilt Medical Center or Brigham and Women's Hospital. Participants must be able to use English or Spanish, have a smartphone or tablet with internet, and an active patient web portal account.Check my eligibility
What is being tested?
The study is testing the 'My Diabetes Care' mobile app for people with Type 2 Diabetes. It aims to understand how users interact with the app, evaluate their experience, and identify any technical issues before a larger-scale trial.See study design
What are the potential side effects?
Since this trial involves using a mobile application rather than medication, traditional side effects are not applicable. However, participants may experience frustration or difficulty if they encounter usability issues with the app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month follow-up (t1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month follow-up (t1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
System Usage
Usability
User Experience - Acceptance
Secondary outcome measures
Change in Diabetes Distress
Change in Diabetes Knowledge
Change in Diabetes Readiness for Change
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: My Diabetes Care (MDC) MobileExperimental Treatment1 Intervention
Patients have access to a patient web portal embedded with the My Diabetes Care (MDC) intervention.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,125 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,521 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,314,999 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary goal of this research initiative?

"The main goal of this trial, evaluated over a one month follow-up (T1), is to assess usability. Secondary outcomes involve measuring the changes in self-care activity with the Summary of Diabetes Self-Care Activity (SDSCA) tool, medication adherence through the Adherence to Refills and Medications Scale (ARMS), and diabetes distress using The Problem Areas in Diabetes Scale (PAID-5)."

Answered by AI

Is registration currently open for participants of this study?

"According to information hosted on clinicaltrials.gov, this trial is not presently enrolling patients; the initial posting was November 1st 2022 and it has been modified most recently on October 19th of that same year. Although no longer recruiting, there are still 1391 other studies requiring participants at present."

Answered by AI

Does the age requirement for this research project preclude individuals over 25 years old?

"To join this research, applicants must be between 18 and 75 years of age. This trial has 192 entries for minors while 1066 patients aged 65+ are also eligible to participate."

Answered by AI

Do I qualify to participate in this medical experiment?

"This clinical trial seeks 90 individuals between 18 and 75 years old that have been diagnosed with diabetes mellitus, type 2. In addition to this criterion, potential participants must also be taking at least one medication for the condition, need access to a smartphone or tablet with internet connectivity, possess an active web portal account (e.g., My Health at Vanderbilt or Patient Gateway), and either speak or read Spanish/English fluently."

Answered by AI
~29 spots leftby Apr 2025